Rejuvination

Rejuvenation can be described as feelings of mild to extreme cognitive refreshment which are felt during the afterglow of certain compounds. The symptoms of rejuvenation often include a sustained sense of heightened mental clarity, increased emotional stability, increased calmness alongside of mindfulness, increased motivation, personal bias suppression, increased focus and decreased depression. At its highest level, feelings of rejuvenation can become so intense that they manifest as the profound and overwhelming sensation of being "reborn" anew. This mindstate can potentially last anywhere from several hours to several months after the substance has worn off.

Rejuvination is most commonly induced under the influence of moderate dosages of hallucinogenic compounds, such as psychedelics and dissociatives. However, it can also occur to a lesser extent under the influence of entactogens, cannnabinoids, and meditation.


Analysis

There are a number of legitimate scientific studies which have concluded that long lasting mental benefits can occur after a drug has been taken. For example, it has been demonstrated that ketamine, even if taken in small doses, is effective for patients suffering from chronic depression and bipolar disorder. Studies have shown[1][2] that the effect of the drug is immediate or within 2 hours and consistent in relieving a patient’s depressive and/or suicidal symptoms, lasting up to 3 days after a single dose.

A similar example includes a study which observed significantly decreased depression scores in terminal cancer patients six months after treatment with psilocybin.[3] An open-label study was carried out in 2016 in the UK to investigate the feasibility, safety and efficacy of psilocybin in treating patients with unipolar treatment-resistant depression with promising results; although the study was small and involved only twelve patients, seven of those patients met formal criteria for remission one week following psilocybin treatment and five of those were still in remission from their depression at three months.[4]


psychoactive substances

Compounds which may cause this effect commonly include:

2C-B, 4-AcO-DMT, 5-MeO-DMT, 5-MeO-DiBF, Ayahuasca, Creatine, DMT, DPT, Ibogaine, LSA, MDMA, N-Acetylcysteine, Noopept, Psilocin, Psilocybin mushroom, Tianeptine

See also


comments

Documentation written by Josie Kins